Lazard Asset Management’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Sell |
509,794
-323,368
| -39% | -$1.11M | ﹤0.01% | 1056 |
|
|
2025
Q1 | $1.86M | Sell |
833,162
-95,432
| -10% | -$213K | ﹤0.01% | 997 |
|
|
2024
Q4 | $2.72M | Sell |
928,594
-167,981
| -15% | -$492K | ﹤0.01% | 783 |
|
|
2024
Q3 | $2.85M | Buy |
1,096,575
+4,406
| +0.4% | +$11.5K | ﹤0.01% | 785 |
|
|
2024
Q2 | $3.23M | Sell |
1,092,169
-927,843
| -46% | -$2.75M | ﹤0.01% | 776 |
|
|
2024
Q1 | $9.15M | Sell |
2,020,012
-1,391,993
| -41% | -$6.31M | 0.01% | 555 |
|
|
2023
Q4 | $19.5M | Buy |
3,412,005
+265,172
| +8% | +$1.51M | 0.02% | 391 |
|
|
2023
Q3 | $14.5M | Sell |
3,146,833
-128,468
| -4% | -$591K | 0.02% | 464 |
|
|
2023
Q2 | $21.2M | Buy |
3,275,301
+32,102
| +1% | +$207K | 0.03% | 387 |
|
|
2023
Q1 | $24.5M | Buy |
3,243,199
+336,987
| +12% | +$2.54M | 0.03% | 359 |
|
|
2022
Q4 | $29.4M | Sell |
2,906,212
-378,810
| -12% | -$3.84M | 0.04% | 319 |
|
|
2022
Q3 | $32.5M | Sell |
3,285,022
-61,475
| -2% | -$608K | 0.05% | 296 |
|
|
2022
Q2 | $35.6M | Buy |
3,346,497
+156,660
| +5% | +$1.67M | 0.05% | 296 |
|
|
2022
Q1 | $31.1M | Buy |
3,189,837
+2,899,091
| +997% | +$28.3M | 0.04% | 366 |
|
|
2021
Q4 | $4.16M | Buy |
290,746
+149,738
| +106% | +$2.14M | ﹤0.01% | 806 |
|
|
2021
Q3 | $2.83M | Buy |
+141,008
| New | +$2.83M | ﹤0.01% | 866 |
|